Schmidt et al., 2001 - Google Patents
Pathogenic aspects of STEC infections in humansSchmidt et al., 2001
- Document ID
- 4637004610120852342
- Author
- Schmidt H
- Karch H
- Bitzan M
- Publication year
- Publication venue
- Verocytotoxigenic E. coli
External Links
Snippet
In 1982, the Centers for Disease Control and Prevention (CDC), Atlanta, reported an outbreak of hemorrhagic colitis (HC) in Oregon and Michigan by a rare Escherichia coli serotype, O157: H7 (24). At the time, no one suspected that this pathogen had begun its …
- 230000001717 pathogenic effect 0 title abstract description 15
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Melton-Celsa et al. | Pathogenesis of Shiga-toxin producing Escherichia coli | |
Proulx et al. | Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome | |
O’Loughlin et al. | Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells | |
Mohawk et al. | Mouse models of Escherichia coli O157: H7 infection and shiga toxin injection | |
Barbuddhe et al. | Listeria as an enteroinvasive gastrointestinal pathogen | |
Navarro‐Garcia | Escherichia coli O104: H4 pathogenesis: an enteroaggregative E. coli/Shiga toxin‐producing E. coli explosive cocktail of high virulence | |
Karmali | Infection by Shiga toxin-producing Escherichia coli: an overview | |
Ketley | Pathogenesis of enteric infection by Campylobacter | |
Welinder-Olsson et al. | Enterohemorrhagic Escherichia coli (EHEC) | |
Ruiz-Perez et al. | Bacterial serine proteases secreted by the autotransporter pathway: classification, specificity, and role in virulence | |
Konkel et al. | The pathogenesis of Campylobacter jejuni-mediated enteritis | |
Darwin et al. | Molecular basis of the interaction of Salmonella with the intestinal mucosa | |
Stiles et al. | Clostridial binary toxins: iota and C2 family portraits | |
LeBlanc | Implication of virulence factors in Escherichia coli O157: H7 pathogenesis | |
Vallance et al. | Enteropathogenic and enterohemorrhagic Escherichia coli infections: emerging themes in pathogenesis and prevention | |
Navarro-Garcia et al. | Autotransporters and virulence of enteroaggregative E. coli | |
Xayarath et al. | Listeria monocytogenes CtaP is a multifunctional cysteine transport‐associated protein required for bacterial pathogenesis | |
Tang et al. | Transport proteins promoting Escherichia coli pathogenesis | |
Mohawk et al. | Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157: H7 | |
Arbus | Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome. | |
Schmidt et al. | Pathogenic aspects of STEC infections in humans | |
Rakin et al. | Yersinia enterocolitica | |
Guth et al. | Shiga toxin-producing Escherichia coli | |
Khan et al. | Shiga toxin producing Escherichia coli infection: current progress & future challenges | |
Hassan et al. | Escherichia coli as a global pathogen |